Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.

Frandsen TL, Heyman M, Abrahamsson J, Vettenranta K, Åsberg A, Vaitkeviciene G, Pruunsild K, Toft N, Birgens H, Hallböök H, Quist-Paulsen P, Griškevičius L, Helt L, Hansen BV, Schmiegelow K.

Eur J Cancer. 2014 Jan;50(2):251-9. doi: 10.1016/j.ejca.2013.09.027. Epub 2013 Nov 11.

PMID:
24231337
2.

Status of the GCP guidelines in Europe.

Geussenhainer S.

Methods Find Exp Clin Pharmacol. 1993 May;15(4):223-8.

PMID:
8361259
3.

Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.

Bilbault P, Belorgey C, Zannad F, Golinelli D, Pletan Y; participants of Round Table n°4 of Giens XXV.

Therapie. 2010 Jul-Aug;65(4):301-8, 291-9. doi: 10.2515/therapie/2010038. Epub 2010 Sep 21. Review. English, French.

PMID:
20854751
4.

A European consistency for functioning of RECs? We just lost our chance.

Waligora M.

J Med Ethics. 2013 Jun;39(6):408-9. doi: 10.1136/medethics-2012-101228. Epub 2012 Dec 8.

PMID:
23222144
6.
7.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
8.

Clinical trials for children with cancer in Europe - still a long way from harmonisation: a report from SIOP Europe.

Pritchard-Jones K; SIOP Europe.

Eur J Cancer. 2008 Oct;44(15):2106-11. doi: 10.1016/j.ejca.2008.07.026. Epub 2008 Aug 29. Review.

PMID:
18757192
9.

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

Moore RA, Derry S, McQuay HJ, Straube S, Aldington D, Wiffen P, Bell RF, Kalso E, Rowbotham MC; ACTINPAIN writing group of the IASP Special Interest Group (SIG) on Systematic Reviews in Pain Relief.

Pain. 2010 May;149(2):173-6. doi: 10.1016/j.pain.2009.08.007. Epub 2009 Sep 11. Review. No abstract available.

PMID:
19748185
10.

[The role of the Danish Medical Products Agency in clinical trials].

Simonsen AC.

Ugeskr Laeger. 2003 Apr 14;165(16):1653-6. Danish.

PMID:
12756821
11.

[Public GCP unit--experiences from the Aarhus University Hospital].

Jørgensen A, Rønnow IL, Nexø E.

Ugeskr Laeger. 2003 Apr 14;165(16):1667-9. Danish.

PMID:
12756826
12.

Stem cell transplantation in children: how to design a new study.

Corbacioglu S; EBMT Paediatric Working Party.

Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S30-4. doi: 10.1038/bmt.2008.51.

PMID:
18545241
13.

The impact of clinical practice guidelines and clinical trials on treatment decisions.

Darling G.

Surg Oncol. 2002 Dec;11(4):255-62. Review.

PMID:
12450561
14.

How to anticipate the assessment of the public health benefit of new medicines?

Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.

Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.

PMID:
18206104
15.

Advances in therapy for childhood non-B-lymphoblastic leukaemia.

Rivera GK.

Baillieres Clin Haematol. 1994 Jun;7(2):273-98. Review.

PMID:
7803902
16.

Breast cancer research and the European Union Clinical Trials Directive.

Williams N.

Breast Cancer Res. 2004;6(4):145-7. Epub 2004 Apr 20.

18.

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations.

Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99. doi: 10.1164/rccm.200801-060ST.

PMID:
19535666
19.

Translation of clinical trials into clinical practice: use of results in formulating guidelines.

Camm AJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S9-14.

PMID:
12950511
20.

Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

Eckert C, von Stackelberg A, Seeger K, Groeneveld TW, Peters C, Klingebiel T, Borkhardt A, Schrappe M, Escherich G, Henze G.

Eur J Cancer. 2013 Apr;49(6):1346-55. doi: 10.1016/j.ejca.2012.11.010. Epub 2012 Dec 19.

PMID:
23265714

Supplemental Content

Support Center